Virological Suppression Sustained With Very Early ART in Neonates With HIV-1
TUESDAY, Dec. 12, 2023 -- For neonates with in utero HIV-1, very early antiretroviral therapy (ART) can achieve sustained virological suppression, according to a study published online Dec. 4 in The Lancet HIV.
Deborah Persaud, M.D., from Johns... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2023 Category: Pharmaceuticals Source Type: news
Very Early ART Can Result in Sustained HIV Suppression in Neonates
(MedPage Today) -- In neonates with acquired in utero HIV infection, administration of antiretroviral therapy (ART) within 48 hours of life can lead to sustained HIV virological suppression by 2 years, a phase I/II proof-of-concept study indicated... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - December 11, 2023 Category: Pediatrics Source Type: news
Virologist warns UK to brace for 'large rise' in Covid cases in the run-up to Christmas
The country could see a spike in cases during the festive period leading up to Christmas, despite levels currently decreasing. (Source: Daily Express - Health)
Source: Daily Express - Health - December 2, 2023 Category: Consumer Health News Source Type: news
Secret Warnings About Wuhan Research Predated the Pandemic
In late October 2017, a US health official from the National Institute of Allergy and Infectious Diseases (NIAID) arrived at the Wuhan Institute of Virology for a glimpse of an eagerly anticipated work in progress. The WIV, a leading research institute, was putting the finishing touches on China’s…#niaid #wiv #western #ecohealthalliance #beijing #ashamgeorge #vanityfair #usdepartmentofenergy #nih #energydepartment (Source: Reuters: Health)
Source: Reuters: Health - November 21, 2023 Category: Consumer Health News Source Type: news
In Early Weeks of Flu Season, COVID-19 Patients Show Milder Symptoms as SARS-CoV-2 Continues to Evolve
Doctors report difficulty differentiating COVID-19 from other viral infections, impacting clinical laboratory test orders Because the SARS-CoV-2 coronavirus is in the same family of viruses that cause the common cold and influenza, virologists expected this virus—which caused the global COVID-19 pandemic—would evolve and mutate into a milder form of infection. Early evidence from this influenza […]
The post In Early Weeks of Flu Season, COVID-19 Patients Show Milder Symptoms as SARS-CoV-2 Continues to Evolve appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 17, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Precision Medicine anatomic pathology Andrew Read PhD Beth Israel Deaconess Medical Center CDC centers for disease contro Source Type: news
Your 2023 Holiday Season Guide to COVID-19, Flu, and RSV
As you make your shopping list, plan travel, and schedule parties this holiday season, there’s something else you should add to your to-do list: making sure you’re up-to-date on the latest guidance around COVID-19, the flu, and RSV, as respiratory disease season hits full swing.
“It’s always important to factor in the possibility of either transmitting an infection to other people or becoming infected, especially when getting together in large groups,” says Matthew Binnicker, director of clinical virology at the Mayo Clinic. “There are ways to safely gather and enjoy the holiday seaso...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir
TUESDAY, Nov. 14, 2023 -- For patients receiving nirmatrelvir-ritonavir (N-R) for acute COVID-19, virologic rebound (VR) occurs in about one in five, according to a study published online Nov. 14 in the Annals of Internal Medicine.
Gregory E.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news
A chikungunya vaccine is nearing approval. Who will get it?
The first vaccine against the mosquito-borne viral disease chikungunya will likely come to market next month. With the debilitating disease now afflicting more than half the countries in the world and threatening to spread further, the imminent U.S. Food and Drug Administration (FDA) approval of the vaccine is “great news,” says Scott Weaver, a virologist at the University of Texas Medical Branch whose own lab started to work on a chikungunya vaccine nearly 2 decades ago.
The vaccine, made by the French company Valneva, will likely be recommended mainly to U.S. travelers at first. But many expect an FDA approval ...
Source: ScienceNOW - October 30, 2023 Category: Science Source Type: news
Africa: Breakthroughs in Medicine - Top Virologist On the Two Most Important Developments for Africa
[The Conversation Africa] There have been several important breakthroughs in medical science recently. Crispr, mRNA, next-generation cancer treatments and game-changing vaccines are some of them. Oyewale Tomori, a virologist with decades-long involvement in managing diseases in Nigeria, gives his verdict on the most significant discoveries and what they mean for Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 24, 2023 Category: African Health Tags: Africa Health and Medicine Source Type: news
Fight Over Covid Lab Leak Stalls Virology Research
Scientists doing “gain-of-function” research said that heightened fears of lab leaks are stalling studies that could thwart the next pandemic virus. (Source: NYT Health)
Source: NYT Health - October 16, 2023 Category: Consumer Health News Authors: Benjamin Mueller and Sheryl Gay Stolberg Tags: Coronavirus Origins Investigation Coronavirus (2019-nCoV) Laboratories and Scientific Equipment Genetic Engineering Research Avian Influenza United States Politics and Government Ferrets Epidemics Viruses National Institutes of Health Source Type: news
Lab Leak Fight Casts Chill Over Virology Research
Scientists doing “gain-of-function” research said that heightened fears of lab leaks are stalling studies that could thwart the next pandemic virus. (Source: NYT Health)
Source: NYT Health - October 16, 2023 Category: Consumer Health News Authors: Benjamin Mueller and Sheryl Gay Stolberg Tags: your-feed-science Coronavirus (2019-nCoV) Research Avian Influenza United States Politics and Government Ferrets Laboratories and Scientific Equipment Epidemics Viruses National Institutes of Health Pennsylvania State University Chin Source Type: news
Can you get COVID-19 and the flu at the same time? A Mayo Clinic expert weighs in
Influenza, COVID-19, the common cold and respiratory syncytial virus (RSV) are among the respiratory viruses that will be circulating this fall and winter seasons. These highly contagious viruses cause similar symptoms, making it difficult to differentiate between them. Those symptoms include: Fever Cough Sore throat Runny nose Body aches Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, says it is possible for people to contract more than one virus at the… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 16, 2023 Category: Databases & Libraries Source Type: news
Potent strain of bluetongue virus is spreading in northern Europe, threatening sheep and cattle
A dreaded pathogen is spreading rapidly among livestock in the Netherlands for the first time in 14 years, killing sheep and sickening cattle. Bluetongue virus (BTV), which is endemic in tropical and subtropical regions, is transmitted by biting insects called midges. It does not infect humans, but the new outbreak is especially concerning because Dutch livestock have been stricken with a potent strain for which no vaccine is available in Europe.
Within 2 weeks of its first detection in the country, the virus had been confirmed in 18 flocks of sheep and 55 cattle herds. And this week a sheep on a farm across the bord...
Source: ScienceNOW - October 11, 2023 Category: Science Source Type: news
Kerala Proved Good Governance Vital in a Pandemic
This article was supported by the Sabin Vaccine Institute and Internews.
IPS UN Bureau Report
Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');
Lawmakers Call on G20 to Prioritise Spending on Youth, Gender, and Human Security
Politics Behind the Removal of Mughal History From Textbooks Say Academics (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - October 6, 2023 Category: International Medicine & Public Health Authors: Ranjit Devraj Tags: Asia-Pacific COVID-19 Featured Headlines Health Humanitarian Emergencies TerraViva United Nations India IPS UN Bureau IPS UN Bureau Report Source Type: news
Alcohol Use Not Tied to Sustained Virologic Response With Hepatitis C Treatment
FRIDAY, Sept. 29, 2023 -- Alcohol use is not associated with lower odds of sustained virologic response (SVR) among patients initiating direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 29, 2023 Category: Pharmaceuticals Source Type: news
